Progress of molecular typing and heterogeneity in hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 386-390, 2021.
Artículo
en Chino
| WPRIM
| ID: wpr-886066
ABSTRACT
Hormone receptor-positive and human epidermal growth factor receptor 2-positive (HR + HER2 +) breast cancer is a highly heterogeneous disease, accounting for about 10% of breast cancers. The molecular biological characteristics, therapeutic effect and prognosis of all subtypes have significant differences. This paper reviews the research progress of molecular biological characteristics, diagnosis and treatment condition and single-cell level in HR + HER2 + breast cancer from the perspective of heterogeneity.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio pronóstico
Idioma:
Chino
Revista:
Cancer Research and Clinic
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS